Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $601.34M.
ENTERPRISE VALUE (EV)
$601.34M
Climb Bio, Inc.
Market Cap
$636.76M
Enterprise Value (EV)
$601.34M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Climb Bio, Inc. (CLYM) | $636.76M | $601.34M |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.03M | $620.14M |
| AngioDynamics, Inc. (ANGO)vs › | $645.20M | $591.33M |
| Aura Biosciences, Inc. (AURA)vs › | $647.51M | $596.27M |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $662.34M | $631.19M |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | $916.11M |
| OrthoPediatrics Corp. (KIDS)vs › | $595.38M | $669.97M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $589.38M | $570.21M |
| Helus Pharma Inc. (HELP)vs › | $688.02M | $521.86M |
| Annexon, Inc. (ANNX)vs › | $689.78M | $515.16M |
Market Cap
$636.76M
Total Debt
$256000.00
Cash
$35.69M
Enterprise Value
$601.34M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
